-
Upper respiratory, cold, allergy and sinus category sees ‘impressive’ growth
The upper respiratory, cold-allergy-sinus liquids and tablets segments combined saw a 4% growth in sales across multi-outlets for the last 12 months compared with the previous year, with growth in drug and food channels for both UR segments. Impressive growth of 7% from cold-allergy-sinus liquids in the drug channel was driven by manufacturer Reckitt Benckiser with 16% growth year over year (Figure 1).
-
Lewis hones broad product strategy
How does Lewis Drug thrive in a crowded and super-competitive marketplace? The company’s success formula is no big secret, said Bob Meyer, SVP of merchandise and marketing, but that doesn’t mean it’s easy to replicate. “[We try] to find niches in the marketplace where we feel we can do better than our competition,” Meyer explained.